“Innovations in Global Health” is a new series featuring promising product or service innovations in global health
Kinnos Inc. is a New York-based company that’s raising the standard of infectious disease decontamination to protect healthcare workers, patients, and the general public. Their first product, Highlight, is a patent-pending additive that greatly improves visibility, coverage, and end-user compliance of disinfectants. Highlight is used by HazMat and biocontainment units, was a winner of the USAID Fighting Ebola Grand Challenge, and has been field-tested in Liberia, Guinea, and Haiti. Kinnos has additionally been recognized as winners of the Lemelson-MIT Student Prize, Collegiate Inventors Competition, and Columbia Venture Competition, and has been featured in the Wall Street Journal, NPR, and Forbes 30 Under 30 in Healthcare.
To learn more about the product and Katherine’s story, watch this short video created for International Day of Women and Girls in Science or visit their website: https://www.kinnos.us/
About the Co-Founder
Katherine Jin is the COO and Co-Founder of Kinnos, a New York-based company that’s raising the standard of infectious disease decontamination to protect healthcare workers and patients. Katherine has previously worked at Mt. Sinai St. Luke’s Hospital and graduated from Columbia University in 2016 with a double major in computer science and biology.
Inclusion in the series is not considered an endorsement by GBCHealth or any members of its Board of Directors. GBCHealth does not endorse or recommend any commercial products, processes, or services.